Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Elderly TKA Patients
NCT06614881Completed
- Sponsor
- Tanta University
- Start
- Jul 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative delirium (POD) and Post-operative cognitive dysfunction (POCD) (4 arms), sponsored by Tanta University. Primary endpoint: Proportion of patients reporting at least a 50% reduction of Postoperative Delirium at 3 months. Started Jul 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT06614881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06614881.